Affiliation:
1. Kazan State Medical Academy, Branch of the Russian Medical Academy of Continuing Professional Education, Ministry of Health of Russia; Republican Clinical and Diagnostic Center for Demyelinating Diseases, Ministry of Health of the Republic of Tatarstan
Abstract
Multiple sclerosis (MS) in children and adolescents is a genuine concern of pediatric neurology that specialists in all countries are dealing with. To date, neither the causes of onset nor the individual components of the pathogenesis of the disease have been reliably clarified, and the modern, changing picture of the clinical manifestation of the disease sometimes complicates timely diagnosis even in adult patients. There are more such questions in pediatric MS.Objective: to study the prevalence and clinical features of MS in children in the Republic of Tatarstan.Material and methods. We conducted a survey and data analysis of 128 children and adolescents aged 0 to 18 years inclusive. The examination of patients included neurological examination according to the classical scheme, neuroimaging examination, neurophysiological examination and cerebrospinal fluid examination. The diagnosis was based on the current (as of the time of diagnosis) criteria of McDonald and the International Pediatrics MS Study Group criteria. The severity of the patients' clinical condition was assessed using the Expanded Disability Status Scale (EDSS).Results. MS was diagnosed in 99 cases (77.3%), clinically isolated syndrome – in 10 (7.8%), acute disseminated encephalomyelitis – in 5 (3.9%), bilateral optic neuritis – in two patients (1.6%), disseminated encephalomyelitis – in one case (0.8%); other central nervous system diseases were diagnosed in 11 (8.6%) patients. After a detailed examination, the group “other diseases of the central nervous system” included such conditions as cerebral angiopathy, neurofibromatosis, brain mass, structural focal epilepsy, sequelae of viral encephalitis, and hereditary leukodystrophy. Among the patients, girls aged 15–17 years predominated. Monofocal manifestations were more frequently observed at debut. Moreover, the absolute predominance of the remitting type of course was also noted.Conclusion. The data obtained suggest a predominance of the predominantly remitting course type of MS with a monofocal onset, which is consistent with data from other studies of MS in pediatric practice.
Subject
Psychiatry and Mental health,Neurology (clinical),Clinical Psychology
Reference17 articles.
1. Hawton A, Goodwin E, Boddy K, et al. Measuring the cost-effectiveness of treatments for people with multiple sclerosis: Beyond quality-adjusted life-years. Mult Scler. 2022 Mar;28(3):346-51. doi: 10.1177/1352458520954172. Epub 2020 Sep 3.
2. Wallin MT, Culpepper WJ, Campbell JD, et al; US Multiple Sclerosis Prevalence Workgroup. The prevalence of MS in the United States: A population-based estimate using health claims data. Neurology. 2019 Mar 5;92(10):e1029- e1040. doi: 10.1212/WNL.0000000000007035. Epub 2019 Feb 15. Erratum in: Neurology. 2019 Oct 8;93(15):688.
3. Boyko AN, Khabirov FA, Khaibullin TI. Rasseyannyy skleroz: kratkoe rukovodstvo dlya prakticheskogo vracha Multiple sclerosis: a brief guide for the doctor. 4th ed., correct and additional. Kazan: Publishing House “MedDoc”; 2020. 116 p. (In Russ.).
4. Клинические рекомендации «Рассеянный склероз», 2022. Доступно по ссылке: https://cr.minzdrav.gov.ru/schema/739_ Сlinical guidelines for multiple sclerosis, 2022.Available from: https://cr.minzdrav.gov.ru/schema/739_ (In Russ.).
5. Wong YYM, de Mol CL, van der Vuurst de Vries RM, et al. Real-world validation of the 2017 McDonald criteria for pediatric MS. Neurol Neuroimmunol Neuroinflamm. 2018 Dec 14;6(2):e528. doi: 10.1212/NXI.0000000000000528